| DC Field | Value | Language |
|---|
| dc.contributor.author | Efremova, O. A. | - |
| dc.contributor.author | Kamyshnikova, L. A. | - |
| dc.contributor.author | Obolonkova, N. I. | - |
| dc.contributor.author | Sviridova, M. S. | - |
| dc.contributor.author | Golivets, T. P. | - |
| dc.contributor.author | Khamnagadayev, I. I. | - |
| dc.date.accessioned | 2022-11-06T11:02:20Z | - |
| dc.date.available | 2022-11-06T11:02:20Z | - |
| dc.date.issued | 2022 | - |
| dc.identifier.citation | Mechanisms of Development of Heart Failure in Chronic Kidney Disease / O.A. Efremova [et al.] // Актуальные проблемы медицины. - 2022. - Т.45, №3.-С. 237-252. - Doi: 10.52575/2687-0940-2022- 45-3-237-252. - Refer.: с. 248-251. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/49263 | - |
| dc.description.abstract | The study of scientific data over the past 5 years has shown that cardiorenal syndrome, which has a
complex and multifactorial pathophysiology, is a clinical problem. Modern pharmacological methods of
treatment are effective, but insufficient to satisfactorily influence or mitigate the progression of
cardiorenal syndrome, therefore, the discovery of new drugs and new therapeutic strategies for
cardiorenal syndrome is a high priority task | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | internal diseases | ru |
| dc.subject | chronic heart failure | ru |
| dc.subject | cardiorenal syndrome | ru |
| dc.subject | pathogenesis | ru |
| dc.subject | comorbid pathology | ru |
| dc.title | Mechanisms of Development of Heart Failure in Chronic Kidney Disease | ru |
| dc.type | Article | ru |
| Appears in Collections: | Т. 45, № 3
|
